Molina N, Vettore O, Lorenzetti B B, Ferreira S H
Braz J Med Biol Res. 1983 Dec;16(4):345-52.
The prostaglandin hyperalgesia and tail immersion tests were used to evaluate the analgesic action of morphine, codeine, d-propoxyphene and pentazocine following intraperitoneal, intraplantar and intracerebroventricular administration to rats. In the prostaglandin hyperalgesia test, all drugs produced a dose-dependent analgesia by the various routes. The rank order of potency after intraperitoneal administration was morphine (100) greater than d-propoxyphene (4) greater than pentazocine (2) greater than codeine (1). Although morphine (ID50 = 4 micrograms) was a very potent analgesic when given intracerebroventricularly, very shallow dose-response curves were obtained with the other substances which promoted less than 30% of inhibition at doses up to 250 micrograms. In the paw, morphine (ID50 = 5 micrograms) was only 5-8 times more potent than pentazocine, propoxyphene and codeine. Thus, in contrast with morphine, intraplantar administration of codeine, pentazocine and d-propoxyphene is much more effective than intracerebroventricular administration. In the tail immersion test the smallest intraperitoneal doses which affected the reaction time were 9 mg/kg morphine, 16.2 mg/kg codeine and pentazocine and 48.6 mg/kg d-propoxyphene. When injected intracerebroventricularly morphine (10 micrograms) was the only opiate that caused a detectable analgesic effect. In the prostaglandin hyperalgesia test, a small dose of naloxone (1 micrograms) given into the rat paw significantly antagonized the analgesic effect of d-propoxyphene, codeine and pentazocine administered either intraperitoneally or intraplantarly. These results clearly indicate that a method involving or mimicking inflammatory hyperalgesia is much more sensitive in detecting opiate analgesia than a method which uses heat as a nociceptive stimulus. Furthermore, our results support the proposition that part of the overall analgesia which follows the systemic administration of opiates is due to a peripheral antinociceptive action.
采用前列腺素致痛觉过敏和尾部浸浴试验,评估吗啡、可待因、右旋丙氧芬和喷他佐辛对大鼠腹腔注射、足底注射和脑室内注射后的镇痛作用。在前列腺素致痛觉过敏试验中,所有药物经不同途径给药后均产生剂量依赖性镇痛作用。腹腔注射后效力顺序为:吗啡(100)>右旋丙氧芬(4)>喷他佐辛(2)>可待因(1)。虽然脑室内注射吗啡(半数抑制剂量=4微克)时镇痛作用很强,但其他物质的剂量-反应曲线很平缓,在高达250微克的剂量下抑制率不到30%。在爪部,吗啡(半数抑制剂量=5微克)的效力仅比喷他佐辛、丙氧芬和可待因强5-8倍。因此,与吗啡不同,可待因、喷他佐辛和右旋丙氧芬足底注射比脑室内注射更有效。在尾部浸浴试验中,影响反应时间的最小腹腔注射剂量分别为:吗啡9毫克/千克、可待因和喷他佐辛16.2毫克/千克、右旋丙氧芬48.6毫克/千克。脑室内注射时,吗啡(10微克)是唯一能产生可检测到的镇痛作用的阿片类药物。在前列腺素致痛觉过敏试验中,向大鼠爪部注射小剂量纳洛酮(1微克)能显著拮抗腹腔注射或足底注射的右旋丙氧芬、可待因和喷他佐辛的镇痛作用。这些结果清楚地表明,一种涉及或模拟炎性痛觉过敏的方法在检测阿片类药物镇痛方面比使用热作为伤害性刺激源的方法更敏感。此外,我们的结果支持这样一种观点,即阿片类药物全身给药后的总体镇痛作用部分归因于外周抗伤害感受作用。